Kaschina Elena, Unger Thomas
Institute of Pharmacology and Toxicology, Charité Hospital, Humboldt University at Berlin, Germany.
Blood Press. 2003;12(2):70-88. doi: 10.1080/08037050310001057.
Angiotensin II (Ang II), the biologically active component of renin-angiotensin system (RAS), acts through two receptor subtypes, the AT1 and the AT2 receptor. All classic physiological effects of Ang II, such as vasoconstriction, aldosterone and vasopressin release, sodium and water retention and sympathetic facilitation, are mediated by the AT1 receptor. Ang II, via its AT1 receptor, is also involved in cell proliferation, left ventricular hypertrophy, nephrosclerosis, vascular media hypertrophy, endothelial dysfunction, neointima formation and processes leading to athero-thrombosis. Recent investigations have established a role for the AT2 receptor in cardiovascular, brain and renal function as well as in the modulation of various biological processes involved in development, cell differentiation, tissue repair and apoptosis. This review summarizes new insights in the regulation, signalling and (patho-) physiological functions of AT1 and AT2 receptors. An extensive review on angiotensin receptors has been published recently (de Gasparo M et al., Pharmacol Rev 2000; 52: 415-72).
血管紧张素II(Ang II)是肾素-血管紧张素系统(RAS)的生物活性成分,通过两种受体亚型即AT1和AT2受体发挥作用。Ang II的所有经典生理效应,如血管收缩、醛固酮和血管加压素释放、钠和水潴留以及交感神经促进作用,均由AT1受体介导。Ang II通过其AT1受体还参与细胞增殖、左心室肥厚、肾硬化、血管中层肥厚、内皮功能障碍、新生内膜形成以及导致动脉粥样硬化血栓形成的过程。最近的研究证实了AT2受体在心血管、脑和肾功能以及在发育、细胞分化、组织修复和细胞凋亡所涉及的各种生物学过程的调节中发挥作用。本综述总结了关于AT1和AT2受体的调节、信号传导及(病理)生理功能的新见解。最近已发表了一篇关于血管紧张素受体的详尽综述(de Gasparo M等人,《药理学评论》2000年;52:415 - 72)。